Kathy Meserve
Senior Director, Investments
Department: Emerging Company DevelopmentContact Information
919-549-8820
About
Kathy Meserve is a Senior Director of Investments within the Emerging Company Development Group at NCBiotech. In this role, Kathy identifies and evaluates early-stage NC-based life science companies for loans, mentors and supports selected companies with business strategy to ensure investor readiness, and provides introductions to aid with follow-on funding, co-development partnerships, licensing, and acquisitions.
Kathy brings over 30 years of experience as a scientist and business executive in the pharmaceutical and biotechnology industry. Prior to joining NCBiotech, as a Business Development Consultant for eight years, Kathy provided European and US pharma, biotech and medtech company clients with market research, business strategy development, introductions to corporate partners and licensors, funding advisory services, scouting, due diligence, marketing support and launch planning to expand their businesses in the US market through corporate partnerships, licensing agreements and US subsidiary establishment. Kathy has been directly responsible for growing several small life sciences companies through various senior Business Development roles.
As Director of Science & Technology Evaluation at Calvert Research, Kathy scouted for and evaluated early-stage pharmaceutical assets for investment and acquisition. In Project Management at GSK, Kathy worked with clinical stage programs, keeping teams on track for on-time regulatory submissions, and also worked on the Commercial Launch of Advair®. Kathy began her career working for 10 years as a formulation scientist at Genentech and GSK, gaining experience with a wide variety of dosage forms.
Kathy earned her B.A. in Biology at the University of California, Santa Cruz, with coursework focused on supporting a career in biotechnology. Throughout her career, she has expanded her education through professional courses in Marketing, Commercialization, Negotiation, Project Management, and Finance.